Using a syngeneic brain tumor model, we previously demonstrated that the shRNA knockdown of GBM cell IDO leads to the suppression of intratumoral Treg accumulation and was associated with a significant improvement in long-term animal subject survival (86) independent of GBM cell IDO metabolism (29). The gene discussed is IDO1; the disease is glioblastoma.